Nanoparticle-based drug delivery systems (DDS) containing peptides offer an innovative approach to effectively treat schizophrenia. Such DDSs hold significant potential to revolutionize therapeutic ...
A new study has revealed that neural inhibition and balanced neural activity in a specific area of the brain is required for recognition memory. The findings could help provide better understanding of ...
Schizophrenia is a complicated mental health disorder accompanied by wide range of symptoms such as hallucinations, impaired cognitive ability, and disorganized speech or behavior. It has been ...
LOS ALTOS, Calif.--(BUSINESS WIRE)--Alto Neuroscience, Inc. (“Alto”) (NYSE: ANRO) today announced the initiation of a Phase 2 double-blind, placebo-controlled study of its transdermal formulation of ...
Karuna Therapeutics focuses on developing therapies that target muscarinic cholinergic receptors to treat psychosis and cognitive impairment in CNS disorders. The Company's lead asset, KarXT, has ...
Results of the EMERGENT-3 trial confirm that the novel investigational antipsychotic xanomeline-trospium (KarXT, Karuna Therapeutics) is effective and well tolerated in adults with schizophrenia ...
“ The results of this first placebo-controlled study assessing the utility of SEP-363856 in patients with schizophrenia are exciting, and we intend to advance the development of this novel ...
Oxytocin, a naturally occurring chemical in the brain, plays a crucial role in various cognitive functions, including memory. A recent study revealed that the activation of neurons in the ...
Schizophrenia is currently treated with older medications with limited efficacy and troublesome side effects that lead many patients to stop taking them. The FDA has approved a novel Bristol Myers ...
After decades of stagnation in the schizophrenia field, Bristol Myers Squibb’s $14 billion deal for Karuna Therapeutics has borne fruit with the approval of a promising new drug. BMS’ first-in-class ...
Schizophrenia is a disorder with readily observable symptoms including hallucinations, delusions, social withdrawal, apathy, and disorganized thinking and behavior. It is also associated with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results